{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:49:23Z","timestamp":1767134963831,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010288.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000}}],"reference-count":38,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010288.pub3","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T12:24:52Z","timestamp":1446812692000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Kana R","family":"Jat","sequence":"first","affiliation":[{"name":"All India Institute of Medical Sciences; Department of Pediatrics; Ansari Nagar New Delhi Delhi India 110029"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh K","family":"Walia","sequence":"additional","affiliation":[{"name":"Govt. Medical College and Hospital (GMCH); Department of Community Medicine; Sector-32 Chandigarh Chandigarh UT India 160030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Khairwa","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research (PGIMER); Department of Pathology; Sector-12 Chandigarh Chandigarh UT India 160012"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"10.1002\/14651858.CD010288.pub3-BIB0001|cit1","unstructured":"Novartis An exploratory study to assess multiple doses of Omalizumab in patients with cystic fibrosis complicated by acute bronchopulmonary aspergillosis (ABPA) Clinicaltrials.gov (www.clinicaltrials.gov) (accessed 21\/01\/2013) 2008 ClinicalTrials.gov Identifier: NCT00787917"},{"issue":"3","key":"10.1002\/14651858.CD010288.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD010288.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1378\/chest.109.6.1536","article-title":"Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis","volume":"109","author":"Becker","year":"1996","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD010288.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1398-9995.2009.02147.x","article-title":"Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis","volume":"65","author":"Brinkmann","year":"2010","journal-title":"Allergy"},{"issue":"11","key":"10.1002\/14651858.CD010288.pub3-BIB0005|cit5","first-page":"900","article-title":"Prevalence of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis in the state of Bahia, Brazil","volume":"34","author":"Costa","year":"2008","journal-title":"Jornal Brasileiro De Pneumologia: Publication Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia"},{"issue":"5","key":"10.1002\/14651858.CD010288.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI119252","article-title":"The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics","volume":"99","author":"Corne","year":"1997","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD010288.pub3-BIB0007|cit7","unstructured":"Deeks JJ Higgins JPT Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 9: \u00a0Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"11","key":"10.1002\/14651858.CD010288.pub3-BIB0008|cit8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002204.pub3","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","author":"Elphick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010288.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1164\/ajrccm.155.6.9196082","article-title":"The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects","volume":"155","author":"Fahy","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010288.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD010288.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.116.3.639","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis","volume":"116","author":"Geller","year":"1999","journal-title":"Chest"},{"issue":"5","key":"10.1002\/14651858.CD010288.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mai.2002.130179","article-title":"Allergic bronchopulmonary aspergillosis","volume":"110","author":"Greenberger","year":"2002","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD010288.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/(SICI)1521-4141(199804)28:04<1155::AID-IMMU1155>3.0.CO;2-6","article-title":"Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy","volume":"28","author":"Hemmann","year":"1998","journal-title":"European Journal of Immunology"},{"key":"10.1002\/14651858.CD010288.pub3-BIB0014|cit14","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010288.pub3-BIB0015|cit15","unstructured":"Higgins JPT Altman DG Sterne JAC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD010288.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2222.2004.1916.x","article-title":"Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma","volume":"34","author":"Holgate","year":"2004","journal-title":"Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology"},{"issue":"12","key":"10.1002\/14651858.CD010288.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/ppul.20907","article-title":"Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab)","volume":"43","author":"Kanu","year":"2008","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD010288.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2741\/994","article-title":"Lymphocytes in allergic bronchopulmonary aspergillosis","volume":"8","author":"Knutsen","year":"2003","journal-title":"Frontiers in Bioscience: A Journal and Virtual Library"},{"key":"10.1002\/14651858.CD010288.pub3-BIB0019|cit19","unstructured":"Knutsen AP Slavin RG Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis Clinical & Developmental Immunology"},{"key":"10.1002\/14651858.CD010288.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"bcr07.2008.0379","DOI":"10.1136\/bcr.07.2008.0379","article-title":"Omalizumab for exacerbations of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis","volume":"pii","author":"Lebecque","year":"2009","journal-title":"BMJ Case Reports"},{"issue":"3","key":"10.1002\/14651858.CD010288.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1034\/j.1399-3003.2000.016003464.x","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis","volume":"16","author":"Mastella","year":"2000","journal-title":"European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology"},{"issue":"4","key":"10.1002\/14651858.CD010288.pub3-BIB0022|cit22","first-page":"863","article-title":"Aspergillosis and atopy in cystic fibrosis","volume":"120","author":"Nelson","year":"1979","journal-title":"American Review of Respiratory Disease"},{"issue":"2","key":"10.1002\/14651858.CD010288.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1378\/chest.115.2.364","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole","volume":"115","author":"Nepomuceno","year":"1999","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD010288.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jaci.2006.02.028","article-title":"Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma","volume":"117","author":"Noga","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD010288.pub3-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003559.pub4","article-title":"Omalizumab for asthma in adults and children","author":"Normansell","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010288.pub3-BIB0026|cit26","first-page":"288","article-title":"Allergic\u00a0bronchopulmonary\u00a0aspergillosis: staging as an aid to management","volume":"99","author":"Patterson","year":"1982","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1002\/14651858.CD010288.pub3-BIB0027|cit27","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD010288.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-86-4-405","article-title":"Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis","volume":"86","author":"Rosenberg","year":"1977","journal-title":"Annals of Internal Medicine"},{"issue":"19","key":"10.1002\/14651858.CD010288.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD010288.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000237010","article-title":"Inhibition of allergic reactions with antibodies to IgE","volume":"107","author":"Shields","year":"1995","journal-title":"International Archives of Allergy and Immunology"},{"issue":"7","key":"10.1002\/14651858.CD010288.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.rmed.2004.11.018","article-title":"Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy","volume":"99","author":"Skov","year":"2005","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD010288.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37 Suppl 3","author":"Stevens","year":"2003","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"9","key":"10.1002\/14651858.CD010288.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1007670717619","article-title":"Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: prevalence and percentage of positive tests in the employed diagnostic criteria","volume":"16","author":"Taccetti","year":"2000","journal-title":"European Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD010288.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1398-9995.2005.00887.x","article-title":"Allergic bronchopulmonary aspergillosis","volume":"60","author":"Tillie-Leblond","year":"2005","journal-title":"Allergy"},{"issue":"1","key":"10.1002\/14651858.CD010288.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/pai.1993.7.43","article-title":"Sensitization to aspergillus and allergic bronchopulmonary aspergillosis in a cystic fibrosis population","volume":"7","author":"Valletta","year":"1993","journal-title":"Pediatric Asthma, Allergy & Immunology"},{"issue":"3","key":"10.1002\/14651858.CD010288.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/thx.2004.035519","article-title":"Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody","volume":"62","author":"Ent","year":"2007","journal-title":"Thorax"},{"issue":"6","key":"10.1002\/14651858.CD010288.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ppul.20804","article-title":"Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis","volume":"43","author":"Zirbes","year":"2008","journal-title":"Pediatric Pulmonology"},{"issue":"9","key":"10.1002\/14651858.CD010288.pub3-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010288.pub2","article-title":"Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","author":"Jat","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010288.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T00:00:00Z","timestamp":1521331200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010288.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:42:24Z","timestamp":1628534544000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD010288.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010288.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}